Sarpes Beverage Participates In ERSP Forum

New York, NY – June 28, 2010 – The Electronic Retailing Self-Regulation Program (ERSP) has determined that Sarpes Beverages LLC can support general efficacy claims for Dream Water, but recommended the marketer modify certain consumer testimonials.

The marketer’s advertising came to ERSP’s attention through ERSP’s routine monitoring of electronic direct-response advertising.

ERSP, the electronic direct-response industry’s self-regulatory forum, is administered by the Council of Better Business Bureaus (CBBB) with policy oversight by the National Advertising Review Council (NARC).

 

ERSP examined claims in online advertising that included:

  • · “The First Water that Helps You Relax and Fall Asleep.”
    • · “Wow, I haven’t been able to sleep in years and in just one night the lemon shot worked. I started feeling really relaxed within just a few minutes o taking the shot…” Susan, Washington dc
  • · “…and in about 20 minutes I started to get pretty tired. I went to bed and fell fast asleep in no time” Emily, Charlotte, NC
  • · “…helped me to fall asleep in like 30 minutes instead of 2 hours.” David, Orlando, FL
  • · “The Dream Water worked better than just the melatonin I had been taking and it’s great.” Ken, Houston TX

 

ERSP determined that the marketer provided a reasonable basis for its core message of product efficacy, as well as its representation that Dream Water is the “First Water that Helps You Relax and Fall Asleep.”

However, ERSP determined that the marketer did not adequately support claims made in consumer testimonials regarding the onset of action (“just a few minutes;” “20 minutes;” “30 minutes”) and recommended the advertiser discontinue such claims.

The company, in its marketer’s statement, said it appreciated ERSP’s review. “We will be vigilant that all media containing any testimonials be thoroughly monitored … ,” the company said.

 

Subscribe to the Ad Law Insights or Privacy Initiatives newsletters for an exclusive monthly analysis and insider perspectives on the latest trends and case decisions in advertising law and data privacy.

 

 

 

 

Latest Decisions

Decision

National Advertising Division Recommends Blueprint Test Preparation Discontinue Certain MCAT Score Improvement Claims

New York, NY – April 22, 2024 – The National Advertising Division recommended Blueprint Test Preparation discontinue certain express and implied claims made in connection with its four MCAT preparation courses, including claims that Blueprint students raise their MCAT scores by 15 or 13 points on average.

Read the Decision Summary
Decision

National Advertising Division Recommends The Princeton Review Discontinue Point Increase Claims for MCAT Test Preparation Services

New York, NY – April 18, 2024 – In a Fast-Track SWIFT challenge, the National Advertising Division recommended that The Princeton Review (TPR) discontinue claims that its students “Score a 515+ on the MCAT or add 15 points depending on your starting score. Guaranteed or your money back.”

Read the Decision Summary
Decision

Direct Selling Self-Regulatory Council Recommends Trades of Hope Discontinue Salesforce Member Earnings Claims

McLean, VA – April 17, 2024 – The Direct Selling Self-Regulatory Council (DSSRC) recommended that Trades of Hope discontinue certain earnings claims made by salesforce members on Facebook and YouTube. 

Read the Decision Summary
Decision

National Advertising Division Recommends Lily of the Desert Nutraceuticals Discontinue “100% Pure Avocado Oil” Claim for Tropical Plantation Avocado Oil

New York, NY – April 15, 2024 – The National Advertising Division recommended that Lily of the Desert Nutraceuticals discontinue the claim “100% Pure Avocado Oil” for its Tropical Plantation Avocado Oil and avoid conveying the unsupported message that the product is 100% pure avocado...

Read the Decision Summary